Ping An Biomedical Co., Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Ping An Biomedical Co., Ltd. (PASW) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of CNY 37.23 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-30.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-01-30
CNY
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2025-09-30 | 37.23M CNY 20-F · filed 2026-01-30 | |
| 2025-03-31 | -26.16K CNY 6-K · filed 2025-09-29 | |
| 2024-09-30 | -458.68K CNY 20-F · filed 2026-01-30 | |
| 2024-03-31 | 378.92K CNY 6-K · filed 2025-09-29 | |
| 2023-09-30 | -575.74K CNY 20-F · filed 2026-01-30 |
USD
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2025-09-30 | $5.23M 20-F · filed 2026-01-30 | |
| 2025-03-31 | -$3.60K 6-K · filed 2025-09-29 |